Skip to main content
ENDO 2026 Main banner

Clifford J. Rosen, MD

Director Clinical & Translational Medicine
Maine Medical Center Research Institute
Scarborough, ME, United States

Dr. Rosen is a bone biologist and clinical endocrinologist. He has thirty years of continual NIH funding first at The Jackson
Laboratory and subsequently at MaineHealth Institute of Research. In the last 15 years the Rosen laboratory has been studying
mesenchymal stem cell fate in the bone marrow with a particular focus on the lineage and fate decisions of pre-adipocytes and preosteoblasts.
This has recently included how these progenitors utilize their bioenergetic programs. Dr. Rosen directs or co-directs a
number of NIH programs including a P20 Core in Physiology as part of the Metabolic Networks COBRE funded by NIGMS as well as
the RECOVER West Virginia Hub for Long COVID. He is a multi-PI with Dr. Mone Zaidi on a recently renewed program project
(U19) on the role of FSH as an aging hormone, and he holds two contracts with the NIH for studying the pathophysiology of Long
COVID with a particular focus on metabolic aspects of this disorder. Dr. Rosen is also the principal investigator for the ten year NNECTR
network funded by NIGMS to establish a clinical research infrastructure in Northern New England. Dr. Rosen has served on two
NIH institute advisory boards, NIA and NIAMS as well as serving as permanent Chair of two NIH review panels from CSR: NIAMS
Clinical Trial Advisory Panel (2005-2012), and Skeletal Biology Development and Diseases (2002-2004). He served as a board
member of the Endocrine Society: 2018-2021, and former president of the American Society of Bone and Mineral Research. Dr.
Rosen has been an associate editor at New England Journal of Medicine for 11 years and has published more than 640 peer review
publications in Nature, Science, New England Journal, Lancet, PNAS, JCI, JCI Insight and Nature Medicine.

Disclosure information not submitted.

Presentation(s):